5-Hydroxytryptamine Limits Pulmonary Arterial Hypertension Progression by Regulating Th17/Treg Balance
Biological and Pharmaceutical Bulletin · 2025
DOI: 10.1248/bpb.b24-00831 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2025. Verfasst von Junli Han und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710114, China. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Th17 Cells, Serotonin, Pulmonary Arterial Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710114, China.
- Department of Critical Care Medicine, Ngari Prefecture People's Hospital, Ngari Prefecture 859000, China.
Zitieren
APA
Han, J., Wang, L., Wang, L., & Lei, H. (2025). 5-Hydroxytryptamine Limits Pulmonary Arterial Hypertension Progression by Regulating Th17/Treg Balance. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b24-00831
Vancouver
Han J, Wang L, Wang L, Lei H. 5-Hydroxytryptamine Limits Pulmonary Arterial Hypertension Progression by Regulating Th17/Treg Balance. Biological and Pharmaceutical Bulletin. 2025. doi:10.1248/bpb.b24-00831
BibTeX
@article{Han2025,
author = {Han, Junli and Wang, Lianghe and Wang, Li and Lei, Hua},
title = {5-Hydroxytryptamine Limits Pulmonary Arterial Hypertension Progression by Regulating Th17/Treg Balance},
journal = {Biological and Pharmaceutical Bulletin},
year = {2025},
doi = {10.1248/bpb.b24-00831}
}
EUVIMED